1474-1475 / 2437
Survival
•
Study permanently
closed for excess of
relapse at interim analysis
•
Estimated 1 y PFS of
53.6% (SE, 10.1%)
•
Median follow up for the
25 survivors was 1.2 years
(0.6 to 2.9 y)
Lucie Lafay-Cousin ASCO meeting Chicago June 03rd 2017